Our products

NeoAzarina

Neoazarina®

coated tablets, OTC drug

Neoazarina® is a drug demonstrating antitussive effects.

Indications for application
In case of strong paroxysmal (especially during night) coughing attacks. In upper airways infections.

 

 

How to apply Neoazarina®

Adults and children over 12 years of age – 1 to 2 tablets 3 times a day.
In case of application of the product in children younger than 12 years of age, its dosage should be decided by a doctor.

In case of taking higher than recommended dose of Neoazarina®
No case of the drug overdose has been reported. In extreme cases taking excessive doses of the drug may cause nausea, vomiting, stomach aches, headaches, depression, respiratory disorders, agitation, profuse sweating, convulsions or even loss of consciousness. In case of taking much higher dose than recommended, it is necessary to contact a physician.

Long-term taking of high doses of the drug may lead to dependence.

In case of skipping the dose of Neoazarina®
Do not apply a double dose in order to supplement the omitted one.

 

Before you apply Neoazarina®

Do not apply Neoazarina® in case of hypersensitivity to any of the drug’s components, in acute attacks of bronchial asthma, respiratory insufficiency, respiration disorders and chronic constipations.
It is not recommended to apply the drug for the period longer than 7 days or to exceed the recommended doses because of the possibility of drug dependence.

Application of Neoazarina® in children
Do not apply the drug in children younger than 6 years of age. In case of children of 6 – 12 years of age, only a physician can make this decision.

Pregnancy
Do not apply the drug during pregnancy. No controlled clinical trials have been conducted in pregnant women.

Breast feeding
Do not apply the drug during breast feeding. No controlled clinical trials have been conducted in breast feeding women.

Driving of vehicles and operation of moving mechanisms
The drug may cause impairment of psychophysical aptitude and for this reason, patients during therapy should not drive vehicles and operate moving mechanisms.

Use of other drugs
Neoazarina® may intensify depressive effects on central nervous system of some anti-depressive drugs (of benzodiazepine group), sleep-inducing drugs (barbituric acid derivatives) and neuroleptics. It intensifies effects of other opioid drugs on respiratory center and intensifies effects of ethyl alcohol. It may also interact with MAO inhibitors, anti-histamine drugs and drugs reducing arterial blood pressure.

 

Possible undesired effects

Undesired effects may occur in the form of nausea, vomiting, constipation, dryness in the mouth, sleep disorders and allergic reactions, e.g. dermal lesions. In case of undesired effects, it is necessary to contact a physician. In case of other undesired effects, not mentioned here, inform your physician about them.

Storage of Neoazarina®

Store at the temperature not exceeding 25°C, out of reach and sight of children.
Do not use the drug after expiry date stated on the package.

 

Composition

Active substances:
Codeine phosphate (Codeiniphosphas hemihydricus) – 10 mg,
Pulverized thyme herb (Thymi herba pulveratum) – 316 mg

Auxiliary substances:
anise oil, potato starch, lactose monohydrate, powidon, talc, makrogol 6000

Unit packaging: 10 tablets.

 

See also